Literature DB >> 28011072

Mortality prediction models in the general trauma population: A systematic review.

Leonie de Munter1, Suzanne Polinder2, Koen W W Lansink3, Maryse C Cnossen4, Ewout W Steyerberg5, Mariska A C de Jongh6.   

Abstract

BACKGROUND: Trauma is the leading cause of death in individuals younger than 40 years. There are many different models for predicting patient outcome following trauma. To our knowledge, no comprehensive review has been performed on prognostic models for the general trauma population. Therefore, this review aimed to describe (1) existing mortality prediction models for the general trauma population, (2) the methodological quality and (3) which variables are most relevant for the model prediction of mortality in the general trauma population.
METHODS: An online search was conducted in June 2015 using Embase, Medline, Web of Science, Cinahl, Cochrane, Google Scholar and PubMed. Relevant English peer-reviewed articles that developed, validated or updated mortality prediction models in a general trauma population were included.
RESULTS: A total of 90 articles were included. The cohort sizes ranged from 100 to 1,115,389 patients, with overall mortality rates that ranged from 0.6% to 35%. The Trauma and Injury Severity Score (TRISS) was the most commonly used model. A total of 258 models were described in the articles, of which only 103 models (40%) were externally validated. Cases with missing values were often excluded and discrimination of the different prediction models ranged widely (AUROC between 0.59 and 0.98). The predictors were often included as dichotomized or categorical variables, while continuous variables showed better performance.
CONCLUSION: Researchers are still searching for a better mortality prediction model in the general trauma population. Models should 1) be developed and/or validated using an adequate sample size with sufficient events per predictor variable, 2) use multiple imputation models to address missing values, 3) use the continuous variant of the predictor if available and 4) incorporate all different types of readily available predictors (i.e., physiological variables, anatomical variables, injury cause/mechanism, and demographic variables). Furthermore, while mortality rates are decreasing, it is important to develop models that predict physical, cognitive status, or quality of life to measure quality of care.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mortality; Prognostic models; Quality assessment; Systematic literature review; Trauma

Mesh:

Year:  2016        PMID: 28011072     DOI: 10.1016/j.injury.2016.12.009

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  35 in total

1.  Injured patients who would benefit from expedited major trauma centre care: a consensus-based definition for the United Kingdom.

Authors:  Gordon Fuller; Samuel Keating; Janette Turner; Josh Miller; Chris Holt; Jason E Smith; Fiona Lecky
Journal:  Br Paramed J       Date:  2021-12-01

2.  Inferring Tissue-Specific, TLR4-Dependent Type 17 Immune Interactions in Experimental Trauma/Hemorrhagic Shock and Resuscitation Using Computational Modeling.

Authors:  Ashti M Shah; Ruben Zamora; Sebastian Korff; Derek Barclay; Jinling Yin; Fayten El-Dehaibi; Timothy R Billiar; Yoram Vodovotz
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

3.  Electronic health record machine learning model predicts trauma inpatient mortality in real time: A validation study.

Authors:  Zongyang Mou; Laura N Godat; Robert El-Kareh; Allison E Berndtson; Jay J Doucet; Todd W Costantini
Journal:  J Trauma Acute Care Surg       Date:  2022-01-01       Impact factor: 3.697

4.  RISC II is superior to TRISS in predicting 30-day mortality in blunt major trauma patients in Hong Kong.

Authors:  Kei Ching Kevin Hung; Chun Yu Lai; Janice Hiu Hung Yeung; Marc Maegele; Po Shan Lily Chan; Ming Leung; Hay Tai Wong; John Kit Shing Wong; Ling Yan Leung; Marc Chong; Chi Hung Cheng; Nai Kwong Cheung; Colin Alexander Graham
Journal:  Eur J Trauma Emerg Surg       Date:  2021-04-26       Impact factor: 3.693

5.  Dynamic Bayesian network for predicting physiological changes, organ dysfunctions and mortality risk in critical trauma patients.

Authors:  Qi Chen; Bihan Tang; Jiaqi Song; Ying Jiang; Xinxin Zhao; Yiming Ruan; Fangjie Zhao; Guosheng Wu; Tao Chen; Jia He
Journal:  BMC Med Inform Decis Mak       Date:  2022-05-03       Impact factor: 3.298

6.  Evolution of Practices in a French Trauma Centre: Decrease in Blood Transfusions and Fresh Frozen Plasma to Red Blood Cell Ratios.

Authors:  Cyril Pernod; Laurie Fraticelli; Guillaume Marcotte; Bernard Floccard; Thibaut Girardot; Clement Claustre; Carlos El Khoury; Thomas Rimmele
Journal:  Turk J Anaesthesiol Reanim       Date:  2021-10

7.  Derivation and validation of different machine-learning models in mortality prediction of trauma in motorcycle riders: a cross-sectional retrospective study in southern Taiwan.

Authors:  Pao-Jen Kuo; Shao-Chun Wu; Peng-Chen Chien; Cheng-Shyuan Rau; Yi-Chun Chen; Hsiao-Yun Hsieh; Ching-Hua Hsieh
Journal:  BMJ Open       Date:  2018-01-05       Impact factor: 2.692

8.  Validation of the trauma mortality prediction scores from a Malaysian population.

Authors:  Jih Huei Tan; Henry Chor Lip Tan; Nur Azlin Md Noh; Yuzaidi Mohamad; Rizal Imran Alwi
Journal:  Burns Trauma       Date:  2017-12-22

9.  Comparative Analysis of the Regulatory T Cells Dynamics in Peripheral Blood in Human and Porcine Polytrauma.

Authors:  Rafael Serve; Ramona Sturm; Lukas Schimunek; Philipp Störmann; David Heftrig; Michel P J Teuben; Elsie Oppermann; Klemens Horst; Roman Pfeifer; Tim P Simon; Yannik Kalbas; Hans-Christoph Pape; Frank Hildebrand; Ingo Marzi; Borna Relja
Journal:  Front Immunol       Date:  2018-03-13       Impact factor: 7.561

10.  Validating performance of TRISS, TARN and NORMIT survival prediction models in a Norwegian trauma population.

Authors:  N O Skaga; T Eken; S Søvik
Journal:  Acta Anaesthesiol Scand       Date:  2017-11-08       Impact factor: 2.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.